Kind Consumer
Business profile
Location: north Wales
Sector: medical technology
Web site: www.kindconsumer.com
Investment
Amount: undisclosed over three investment
rounds
Type: syndication with a number of
investors
Regional manager: Nick
Bradley
Why we invested
Early stage company Kind Consumer developed a
smoking-replacement technology. It is designed to surpass existing
nicotine replacement therapies, safely and affordably.
The company demonstrated a strong management team and a thorough
understanding of the medical
technology markets, making this investment opportunity very
attractive for business angels.
The outcome
Within three months of introducing Kind Consumer to xénos
network members, the company had secured investment. It's now in
its third investment round.
With the potential to save lives with its technology, Kind
Consumer is now in talks with potential commercial partners.
Testimonials
"As well as the significant investment, the xénos angels',
expertise and connections are helping Kind
Consumer to fulfil its ambitions of becoming a global industry
leader. xénos’ contribution to date has been critical, and the
level of professionalism unparalleled.” Dr Sam Bakri, chief
executive and founder, Kind Consumer.
"Kind Consumer is a good example of an early stage company
making the most of its intellectual property to
attract the right level of investment at the appropriate time in
its development." Nick Bradley, xénos regional manager.